Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Total Liabilities (2016 - 2017)

Bone Biologics (BBLG) has disclosed Total Liabilities for 2 consecutive years, with $11.8 million as the latest value for Q3 2017.

  • On a quarterly basis, Total Liabilities rose 53.23% to $11.8 million in Q3 2017 year-over-year; TTM through Sep 2017 was $11.8 million, a 53.23% increase, with the full-year FY2016 number at $9.1 million, changed N/A from a year prior.
  • Total Liabilities was $11.8 million for Q3 2017 at Bone Biologics, up from $10.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $11.8 million in Q3 2017 to a low of $7.5 million in Q1 2016.